Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$365K Buy
2,841
+74
+3% +$8.66K 0.23% 82
2026
Q1
$333K Buy
2,767
+355
+15% +$41K 0.25% 82
2025
Q4
$254K Sell
2,412
-532
-18% -$49.9K 0.19% 95
2025
Q3
$247K Buy
2,944
+1
+0% +$82 0.18% 102
2025
Q2
$233K Buy
2,943
+16
+0.5% +$1.27K 0.19% 111
2025
Q1
$263K Sell
2,927
-375
-11% -$35K 0.25% 92
2024
Q4
$328K Buy
+3,302
New +$340K 0.3% 77

Other funds holding MRK

AGH Wealth Advisors's MRK Position: Q2 2026 in Review

AGH Wealth Advisors increased its Merck (MRK) stake by 2.7% in Q2 2026, buying an estimated $8.66K and bringing the position to 2,841 shares worth $365K. The position accounts for 0.23% of the portfolio, ranked #82.

AGH Wealth Advisors first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • AGH Wealth Advisors held 2,841 shares of Merck worth $365K as of Q2 2026.
  • AGH Wealth Advisors bought 74 Merck shares in Q2 2026, an estimated $8.66K.
  • Merck made up 0.23% of AGH Wealth Advisors's portfolio in Q2 2026, its #82 holding.
  • AGH Wealth Advisors first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • 3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on AGH Wealth Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.